Istockphoto 1127069581 612x612

Postmarket Surveillance Service (PMSS)

Turn Postmarket Data Into a Competitive Advantage

Postmarket surveillance is no longer just about compliance—it’s about continuous product performance, risk visibility, and faster decision-making.

As global regulatory expectations increase, manufacturers must do more than collect complaints and submit reports. They must demonstrate a proactive, data-driven system that continuously monitors product performance, identifies emerging risks, and drives improvement.

RQMIS helps you build and operate a modern, scalable postmarket surveillance program that strengthens compliance, reduces risk, and improves product quality across the entire lifecycle.

The Reality: Postmarket Surveillance Is Getting Harder

Many organizations still rely on fragmented systems and manual processes—leading to:

  • Delayed complaint investigations
  • Inconsistent adverse event reporting
  • Limited visibility into product performance trends
  • Increased risk of FDA observations and warning letters
  • High costs associated with recalls and quality events

Poor postmarket systems don’t just create compliance risk—they impact patient safety, brand reputation, and revenue.

A Smarter Approach to Postmarket Surveillance

RQMIS transforms postmarket surveillance from a reactive function into a proactive, integrated system.

We combine:

  • Deep regulatory expertise
  • Structured quality processes
  • Advanced data analysis and trend identification
  • Scalable operational support

The result: a postmarket surveillance program that is audit-ready, efficient, and continuously improving.

What We Deliver

Complaint Handling & Investigation

We design and execute structured complaint handling processes that are compliant, consistent, and scalable.

  • Intake, triage, and investigation workflows
  • Root cause analysis and documentation
  • Standardized templates for faster, repeatable processing
  • Trend analysis across product families

Effective complaint handling is one of the most critical—and most frequently cited—areas in FDA inspections.

Adverse Event & Regulatory Reporting

We ensure timely, accurate reporting to global regulatory authorities.

  • FDA Medical Device Reporting (MDR – 21 CFR 803)
  • EU Vigilance reporting
  • Health Canada and UK reporting requirements
  • Complete submission support and documentation

Our team helps you avoid underreporting, overreporting, and regulatory scrutiny.

Quality Metrics & Trend Analysis

We turn your postmarket data into actionable insights.

  • Identification of recurring failure modes
  • Statistical trend analysis and signal detection
  • Feedback into risk management (ISO 14971)
  • Support for design improvements and CAPA

A well-structured PMS system enables early detection of quality issues and continuous product improvement.

CAPA & Recall Support

When issues arise, response speed and documentation matter.

  • Corrective and Preventive Action (CAPA) management
  • Recall strategy and execution (21 CFR 806/810)
  • Health Hazard Analysis (HHA)
  • Regulatory communication support

We help you respond decisively—while maintaining compliance and minimizing disruption.

Post-Market Clinical Follow-Up (PMCF) & Registries

Real-world data is critical to demonstrating long-term safety and performance.

  • PMCF study design and execution
  • Registry development and management
  • Real-world evidence collection and analysis
  • Integration with Clinical Evaluation Reports (CER)

Built for Global Compliance

Our PMSS programs are aligned with global regulatory requirements, including:

  • FDA (21 CFR 820, 803, 806, 822)
  • ISO 13485
  • ISO 14971
  • EU MDR / IVDR
  • UK MDR
  • Health Canada

These frameworks require manufacturers to collect, analyze, and act on postmarket data continuously—not just react to issues.

From Reactive to Proactive Surveillance

Traditional postmarket surveillance focuses on reacting to complaints.

Modern systems go further:

  • Continuous data collection across multiple sources
  • Proactive trend detection before issues escalate
  • Integration with risk management and design controls
  • Ongoing feedback into product lifecycle decisions

This shift is now expected under evolving global regulations and quality system requirements.

The Outcome

With RQMIS, you gain:

  • Faster complaint resolution and reporting timelines
  • Reduced risk of regulatory findings and recalls
  • Improved product performance and patient safety
  • Scalable processes without increasing internal headcount
  • A fully auditable, inspection-ready postmarket system

Ready to Strengthen Your Postmarket Surveillance Program?

Whether you need to build a program from scratch, fix compliance gaps, or scale operations globally, RQMIS provides the expertise and infrastructure to support you.